Literature DB >> 7969912

Distribution of manganese-dependent superoxide dismutase in the human brain.

P Zhang1, P Anglade, E C Hirsch, F Javoy-Agid, Y Agid.   

Abstract

The distribution of manganese-dependent superoxide dismutase, an enzyme that transforms superoxide radicals into hydrogen peroxide, was studied in the human brain post mortem using a sheep polyclonal antiserum raised against the enzyme from liver mitochondria. One band, corresponding to a protein of 22,000 mol. wt was detected in the human brain by western blot analysis. At the light-microscopy level, a punctate immunostaining was observed in the neuropil and in some but not all, glial and neuronal cell bodies. Electron-microscopy revealed that the staining was exclusively confined to the inner mitochondrial membrane. A heterogeneous distribution of manganese-dependent superoxide dismutase was observed in the human brain. In the forebrain, numerous immunostained neurons were detected in the striatum, thalamus, pallidal complex and the nucleus basalis of Meynert. In the cerebellum, only granular and Purkinje cells were immunostained. Various nuclei from the brainstem displayed superoxide dismutase immunoreactivity, including the cranial nerve nuclei, the nucleus supratrochlearis, the red nucleus, the substantia nigra, the nucleus cuneiformis and subcuneiformis, the nucleus parabigeminal, the nucleus centralis superior, the nucleus supraspinalis, the nucleus of the medullae oblongata and the gigantocellularis nucleus. Large pyramidal neurons containing superoxide dismutase were detected in the CA subsectors, the hilus of the hippocampus and the cerebral cortex. Smaller immunostained neurons were also observed in layers I, IV and VI of all cortical regions studied. The distribution of immunostained glial cells was more limited, and restricted to the internal and external capsules, the hypothalamus, the red nucleus, the pyramidal white matter and surrounding areas, the cerebral cortex and the sub-ependymal layer, the alveus and the stratum oriens of the hippocampus. This heterogeneous but not ubiquitous distribution of cells expressing manganese-dependent superoxide dismutase suggests that not all cells in the human brain are protected to the same extent against the deleterious effects of superoxide.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7969912     DOI: 10.1016/0306-4522(94)90234-8

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  12 in total

1.  Changes in the ultrastructure of the rat cerebral cortex after oral doses of manganese chloride.

Authors:  T Z Bikashvili; A A Shukakidze; G I Kiknadze
Journal:  Neurosci Behav Physiol       Date:  2001 Jul-Aug

2.  Brain aging phenomena in migrating sockeye salmon Oncorhynchus nerka nerka.

Authors:  M E Götz; C R Malz; A Dirr; D Blum; W Gsell; S Schmidt; R Burger; S Pohli; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  2005-01-31       Impact factor: 3.575

3.  Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease.

Authors:  S Hunot; B Brugg; D Ricard; P P Michel; M P Muriel; M Ruberg; B A Faucheux; Y Agid; E C Hirsch
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

4.  Regulation of intracellular manganese homeostasis by Kufor-Rakeb syndrome-associated ATP13A2 protein.

Authors:  Jieqiong Tan; Tongmei Zhang; Li Jiang; Jingwei Chi; Dongshen Hu; Qian Pan; Danling Wang; Zhuohua Zhang
Journal:  J Biol Chem       Date:  2011-07-01       Impact factor: 5.157

5.  FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells.

Authors:  S Hunot; N Dugas; B Faucheux; A Hartmann; M Tardieu; P Debré; Y Agid; B Dugas; E C Hirsch
Journal:  J Neurosci       Date:  1999-05-01       Impact factor: 6.167

6.  Copper/zinc superoxide dismutase expression in the human central nervous system. Correlation with selective neuronal vulnerability.

Authors:  C Bergeron; C Petrunka; L Weyer
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

7.  Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus.

Authors:  A Furuta; D L Price; C A Pardo; J C Troncoso; Z S Xu; N Taniguchi; L J Martin
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

8.  Association of SOD2, a mitochondrial antioxidant enzyme, with gray matter volume shrinkage in alcoholics.

Authors:  Vibhuti Srivastava; Beata Buzas; Reza Momenan; Gabor Oroszi; Attila J Pulay; Mary-Anne Enoch; Daniel W Hommer; David Goldman
Journal:  Neuropsychopharmacology       Date:  2009-12-30       Impact factor: 7.853

9.  Basal Ganglia disorders associated with imbalances in the striatal striosome and matrix compartments.

Authors:  Jill R Crittenden; Ann M Graybiel
Journal:  Front Neuroanat       Date:  2011-09-07       Impact factor: 3.856

10.  Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration : early loss of TH in striosomes after methamphetamine.

Authors:  Noelia Granado; Sara Ares-Santos; Esther O'Shea; Carlos Vicario-Abejón; M Isabel Colado; Rosario Moratalla
Journal:  Neurotox Res       Date:  2009-09-04       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.